Dipeptidyl Peptidase 4 Inhibitor Drug Class List
✉ Email this page to a colleague
Drugs in Drug Class: Dipeptidyl Peptidase 4 Inhibitor
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Zydus Lifesciences | ZITUVIO | sitagliptin | TABLET;ORAL | 211566-001 | Oct 18, 2023 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Zydus Lifesciences | ZITUVIO | sitagliptin | TABLET;ORAL | 211566-002 | Oct 18, 2023 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Zydus Lifesciences | ZITUVIO | sitagliptin | TABLET;ORAL | 211566-003 | Oct 18, 2023 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
Zydus Lifesciences | ZITUVIMET | metformin hydrochloride; sitagliptin | TABLET;ORAL | 216743-001 | Nov 3, 2023 | RX | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |